{
  "pmcid": "7565906",
  "sha256": "07f12ff1594f87cf47c9430a8fd290db04bd7b32168ffe6e4e5d3dc4d491926e",
  "timestamp_utc": "2025-11-09T22:55:50.602332+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.273280423280426,
    "reading_ease": 39.72833333333335,
    "word_count": 216
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Dobutamine vs Phenylephrine on Graft Flow in Cerebral Bypass Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised crossover trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "10 adult patients undergoing cerebral bypass surgery at the University Medical Centre Utrecht"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomly assigned to receive dobutamine to increase cardiac index or phenylephrine to increase mean arterial pressure (MAP)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine whether dobutamine administration results in greater graft perfusion than phenylephrine"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the absolute change in graft flow between the reference and intervention phases"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using sealed opaque envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "the anaesthesiologist was blinded to graft flow measurements"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "10 adult patients undergoing cerebral bypass surgery at the University Medical Centre Utrecht were included between September 2018 and July 2019"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Graft flow increased with a median of 4.1 ml/min (IQR, 1.7–12.0) after dobutamine and 3.6 ml/min (IQR, 1.3–7.8) after phenylephrine (difference –0.6 ml/min; 95% CI, –14.5 to 5.3; P = 0.441)"
      },
      "Harms": {
        "score": 1,
        "evidence": "One patient experienced a short episode of atrial arrhythmia during dobutamine administration, with no haemodynamic consequences"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Netherlands Trial Register, NL7077"
      },
      "Funding": {
        "score": 1,
        "evidence": "Departmental sources"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}